https://www.selleckchem.com/pr....oducts/Erlotinib-Hyd
Predictors of improved survival were female gender, higher income, lower stage, no chemotherapy, academic facility, and more remote year. There was no difference in survival between 3D-CRT and IMRT across all stages. CONCLUSIONS The rate of IMRT use for early stage glottic laryngeal cancer has increased over time. There was no difference in outcome in patients receiving IMRT versus 3D-CRT across the cohort.Radiotherapy (RT) has been used for decades as one of the main treatment modalities for cancer patients. The therape
Like
Comment
Share
